Bicara Therapeutics Inc (BCAX)

$BCAX: Anyone else seeing a DoubleBottom on the 100day chart

Now at $13.75.

Looks like its emerging from that.

Now at $13.75

PTs outstanding there from over $30 to $50 on this one............. now only $13.60


Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and it developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company's bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, is a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.

GO $BCAX